ResearchPreclinical ResearchTranslational Research Projects back Re-screening for novel CD40-TRAF6 interaction inhibitors (TRAF-STOPs 2.0) Funded period 2021 – 2021 Granted budget € 405,710 Indication atherosclerosis Therapeutic Principle Drug Principal Investigator Dorothee Atzler, Christian Weber, Esther Lutgens (Hospital of Ludwig Maximilian University of Munich)
